Close Menu

HIV

The FDA approved an additional intended use for Roche's licensed Cobas TaqScreen MPX nucleic acid test to screen donated source plasma.

According to ViiV CEO Dominique Limet, the new company’s unique structure has the potential to “re-energize” the pharmaceutical industry’s involvement in driving HIV treatment innovation and improving access.

Genetic benefit management company Generation Health will assist the nation’s largest pharmacy services provider, CVS Caremark, to extend pharmacogenomics testing services to its pharmacy benefit management customers.

A new study suggests reversed-transcribed HIV-1 viruses that aren't integrated into the human genome have a chromatin structure and are transcriptionally silenced by epigenetic modifications.

The company said it is working with the City of Hope to investigate the vector-based delivery of an anti-HIV RNA cocktail composed of pHIV7, an shRNA targeting an exon in HIV-1 tat/rev, and a Tar decoy.

Last week's ruling "is a complete victory for Roche," an attorney for the company told GenomeWeb Daily News.

The agreement covers systems for HIV and hepatitis B management.

In an interview with Pharmacogenomics Reporter this week, Hakan Sakul provided a snapshot of Pfizer's efforts in personalized medicine, the company's stance on regulatory issues, and its overall focus on "omics"-guided medicine.

Using an siRNA screen, a team of researchers from Boston and Maryland has identified a host of human proteins that appear to play a role in hepatitis C infection.

The company will use an SBIR and an STTR grant to develop POC tests for HIV and respiratory diseases.

Pages

Rady Children's Institute for Genomic Medicine and Deloitte are looking into the use of drones to transport samples for testing. 

Direct-to-consumer genetic testing firm 23andMe is laying off about 100 people.

Researchers from Northwestern University examined dust for antibiotic-resistance genes, New Scientist reports. 

In Science this week: researchers present a computational method for predicting cellular differentiation state from single-cell RNA sequencing data, and more.